Notice on the Supervision of E-cigarette Product Quality Inspection

Sep.30.2024
Notice on the Supervision of E-cigarette Product Quality Inspection
Shenzhen Tobacco Monopoly Bureau issues notice on quality check plan for e-cigarette products sold in Shenzhen in the second half of 2024.

The Shenzhen Tobacco Monopoly Bureau has issued a notice regarding the release of the quality supervision and spot check plan for e-cigarette products sold in Shenzhen in the second half of 2024.

Notice on the Supervision of E-cigarette Product Quality Inspection


According to the relevant provisions of the "Implementation Rules for Quality Supervision Spot Checks of e-cigarette Products" (National Tobacco Bureau [2022] No. 59), the Shenzhen Tobacco Monopoly Bureau has organized the formulation of the "Supervision and Spot Check Program for the Quality of e-cigarette Products Sold in Shenzhen in the Second Half of 2024," which is now being announced.

Notice on the Supervision of E-cigarette Product Quality Inspection


The Shenzhen Tobacco Monopoly Bureau

Notice on the Supervision of E-cigarette Product Quality Inspection


September 29, 2024


The plan for quality supervision spot checks on e-cigarette products sold in Shenzhen in the second half of 2024.


Sampling method


By randomly sampling, 75 smoking accessories and compatible pods (or combination products) of each type are selected, as well as at least 80 grams of aerosolized material, divided into test samples and backup samples as required. Test samples are sent to the relevant testing institution, while backup samples are temporarily stored at the institution responsible for sampling and used as needed for spot checks. The sampling form can be found in Appendix 1.


2. Examination criteria


Judgment Rules


Based on standards.


GB 41700 refers to an e-cigarette product.


3.2 Judgment principle


After conducting tests, it was found that all tested items met the standard requirements, determining the randomly sampled products to be compliant. If any item in the test does not meet the standard requirements, the randomly sampled product is considered non-compliant.


4. Conclusion


This scheme is applicable for quality supervision spot checks on e-cigarette products sold within Shenzhen city in the second half of 2024.


Appendix 1: Sample List of E-cigarette Products


Appendix 2: Method for detecting additives in e-cigarette aerosols.


Appendix 1


E-cigarette product sampling form (applicable to individual or combined sales of smoking products, pods)


Reference Number:


Sampling Unit (Official Seal): Sampled Unit (Official Seal):


Sample person: Investigator


E-cigarette Product Sampling Form (for disposable e-cigarette products)


Serial number:


Sampling unit (official stamp): Sampled unit (official stamp):


Sample person: Handler:


Appendix 2


Method for detecting additives in e-cigarette aerosols


E-cigarette aerosol additives determination of ester compounds and D-limonene by gas chromatography-mass spectrometry (Q/CTQTC122-2021).


E-cigarette aerosol additives determination of alcohol compounds by gas chromatography" (Q/CTQTC124-2021).


E-cigarette aerosol additive determination of catechins and epicatechins by spectrophotometry and high-performance liquid chromatography" (Q/CTQTC125-2021), this spot check only measures catechins.


E-cigarette vapor additives Determination of heterocyclic compounds Gas chromatography-mass spectrometry coupling method (Q/CTQTC121-2021).


E-cigarette aerosol additive determination of ketones by gas chromatography-mass spectrometry" (Q/CTQTC123-2021).


The determination of e-cigarette aerosol additives such as eugenol, maltol, ethyl maltol, vanillin, and ethyl vanillin by high-performance liquid chromatography (Q/CTQTC126-2021).


Title: Determination of Volatile Fatty Acids (Acetic Acid, Propionic Acid, Butyric Acid, and 2-Methylbutyric Acid) in E-Cigarette Aerosol Additives by Gas Chromatography-Mass Spectrometry Coupled Method (Q/CTQTC127-2021)


Analysis of Non-volatile Organic Acids in E-liquid Additives for E-cigarettes by Liquid Chromatography-Tandem Mass Spectrometry (Q/CTQTC128-2021)


Since the submission deadline for Pre-Market Tobacco Product Applications (PMTA) in September 2020, the agency has only authorized three types of electronic cigarette devices.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
In an interview with Romanian marketing publication IQads, Marek Gębski, Director of Smoke-Free Products at Philip Morris Romania, said IQOS experience spaces are evolving from traditional retail locations into platforms for consumer engagement and brand connection. Through locations such as IQOS Boutique Victoriei, PMI aims to use design, culture and consumer experiences to strengthen communication with adult consumers about smoke-free products. The interview highlights how tobacco companies are expanding smoke-free strategies beyond products toward experiential marketing and consumer relationships.
Aug.11
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10